Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hao Xie

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

American journal of clinical oncology

Cancer

Cancers

Therapeutic advances in medical oncology

Yale-New Haven Hospital

Princeton University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yale-New Haven Hospital Jun 11o 2014

United States

Resident Physician :: Internal Medicine

Education History

Princeton University Jan 2o 2006 - Jun 12o 2009

United States

PHD :: Chemistry

Publications

Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer. American journal of clinical oncology (2023)
Junjia Liu, Hao Xie
BRAF Non-V600 Mutations in Metastatic Colorectal Cancer. Cancers 15 (18) (2023)
Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer. American journal of clinical oncology 46 (2) (2022)
Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer. American journal of clinical oncology 46 (2) (2022)
Yujia Bian, Diego Alem, Francisca Beato, Tara L Hogenson, Xinrui Yang, Kun Jiang, Jianfeng Cai, Wen Wee Ma, Martin Fernandez-Zapico, Aik Choon Tan, Nicholas J Lawrence, Jason B Fleming, Yu Yuan, Hao Xie
Development of SOS1 Inhibitor-Based Degraders to Target KRAS -Mutant Colorectal Cancer. Journal of medicinal chemistry (2022)
Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer. American journal of clinical oncology 46 (2) (2022)
Junjia Liu, Xuefeng Wang, Ibrahim H Sahin, Iman Imanirad, Seth I Felder, Richard D Kim, Hao Xie
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer. American journal of clinical oncology 46 (2) (2022)
Siddhartha Yadav, Dhauna Karam, Irbaz Bin Riaz, Hao Xie, Urshila Durani, Narjust Duma, Karthik V Giridhar, Tina J Hieken, Judy C Boughey, Robert W Mutter, John R Hawse, Rafael E Jimenez, Fergus J Couch, Roberto A Leon Ferre, Kathryn J Ruddy
Reply to On the proportion of male breast cancer among all breast cancers. Cancer 126 (9) (2020)
Hao Xie, Junjia Liu, Jun Yin, John R Ogden, Amit Mahipal, Robert R McWilliams, Mark J Truty, Tanios S Bekaii-Saab, Gloria M Petersen, Aminah Jatoi, Joleen M Hubbard, Wen Wee Ma
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. The oncologist 25 (11) (2020)
Hao Xie, Jacqueline M Lafky, Bruce W Morlan, Philip J Stella, Shaker R Dakhil, Gerald G Gross, William S Loui, Joleen M Hubbard, Steven R Alberts, Axel Grothey
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance). Therapeutic advances in medical oncology 12 (2020)
Hao Xie, Douglas W Mahoney, Patrick H Foote, Kelli N Burger, Karen A Doering, William R Taylor, Sara S Then, Xiaoming Cao, Maria McGlinch, Calise K Berger, Tsung-Teh Wu, Joleen M Hubbard, Hatim T Allawi, Michael W Kaiser, Graham P Lidgard, David A Ahlquist, John B Kisiel
Novel Methylated DNA Markers in the Surveillance of Colorectal Cancer Recurrence. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Siddhartha Yadav, Dhauna Karam, Irbaz Bin Riaz, Hao Xie, Urshila Durani, Narjust Florez, Karthik V Giridhar, Tina J Hieken, Judy C Boughey, Robert W Mutter, John R Hawse, Rafael E Jimenez, Fergus J Couch, Roberto A Leon-Ferre, Kathryn J Ruddy
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer 126 (1) (2019)
Hao Xie, Jun Yin, Manisha H Shah, Michael E Menefee, Keith C Bible, Diane Reidy-Lagunes, Madeleine A Kane, David I Quinn, David R Gandara, Charles Erlichman, Alex A Adjei
A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma. Investigational new drugs 37 (4) (2019)
Hao Xie, Brooke D Paradise, Wen Wee Ma, Martin E Fernandez-Zapico
Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer. Cells 8 (5) (2019)

Hao Xie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hao Xie